I'd be keen to know how Paul came up with the three month timeframe in the April announcement.
Everything I have found related to the FDA review process would say this was optimistic at best.
From the information available regarding the process, I would have expected up to 6 months (as a good result).
Hopefully the PAR team do have a better handle on it than me.
Mind you, 6 months is also getting closer ...
I'd like to be wrong and see today's little blip as a sign of something in the works, but I suspect I'm not and will return to having 6 months in my head.
PAR. SP, page-1067
-
- There are more pages in this discussion • 186 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.0¢ |
Change
0.010(5.00%) |
Mkt cap ! $73.48M | |||
| Open | High | Low | Value | Volume |
| 22.5¢ | 23.5¢ | 20.0¢ | $1.067M | 4.986M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1519 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 59999 | 2 |
View Market Depth
| Last trade - 16.10pm 31/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |